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Summary
A Prader-Willi syndrome patient is described who has a
de novo balanced translocation, (4;15)(q27;q11.2)pat,
with breakpoints lying between SNRPN exons 2 and 3.
Parental-origin studies indicate that there is no unipar-
ental disomy and no apparent deletion. This patient ex-
presses ZNF127, SNRPN exons 1 and 2, IPW, and
D15S227E (PAR1) but does not express either SNRPN
exons 3 and 4 or D15S226E (PAR5), as assayed by re-
verse transcription–PCR, of peripheral blood cells.
Methylation studies showed normal biparental patterns
of inheritance of loci DN34/ZNF127, D15S63, and
SNRPN exon 1. Results for this patient and that re-
ported by Sun et al. support the contention that an intact
genomic region and/or transcription of SNRPN exons
2 and 3 play a pivotal role in the manifestations of the
major clinical phenotype in Prader-Willi syndrome.
Introduction
Prader-Willi syndrome (PWS) affects 1/10,000–20,000
live births (Holm et al. 1993) and is characterized by
neonatal hypotonia and failure to thrive, mental retar-
dation, hypogonadism, short hands and feet, and hy-
perphagia resulting in obesity (Prader et al. 1956; Holm
et al. 1993). Approximately 70% (Ledbetter et al. 1981)
of PWS patients have a recognizable deletion (3–4 Mbp)
of chromosome 15q11.2, on their paternally-derived
chromosome (Butler and Palmer 1983). Most of the re-
maining cases have maternal disomy (Nicholls et al.
1989), a situation in which the child inherits two chro-
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mosomes 15 from the mother but in which there is no
contribution from the father. A minority of PWS patients
have very small (20–100 kbp) deletions of 15q11.2, in
an area proximal to the small nucleoriboprotein N
(SNRPN) gene, in a locus that has been proposed as the
imprint-control element (ICE) (Sutcliffe et al. 1994; Buit-
ing et al. 1995). This locus plays a major role in erasing
the inherited imprint status of genes in 15q11.2 and
establishing a new imprint status. PWS patients with
such deletions have normal, biparental inheritance of
loci within 15q11.2; however, they do not express pa-
ternally derived genes. Some of these genes (i.e.,
ZNF127) can be 11 Mb from the ICE. Several cases of
a new rare class of PWS patients have been described
that have balanced translocations involving 15q11.2
(Schulze et al. 1996; Sun et al. 1996). We here describe
a patient with typical PWS and a balanced translocation
(4;15)(q27;q11.2) that breaks between exons 2 and 3 of
the SNRPN gene and that will help to define clinical/
molecular correlations in this contiguous-gene syn-
drome.
Subject and Methods
Subject
The patient is a male born to nonconsanguineous par-
ents of African American descent who were 22 years of
age. The pregnancy was remarkable because of de-
creased fetal movement. Apgars were 6/8. The patient
has one healthy brother, two healthy half-brothers, and
a healthy half-sister, who are all normal. He has a pa-
ternal uncle who weighs 300 lbs but who is of normal
intelligence. At age 19 mo the patient was diagnosed
with IgG-4 deficiency, and therapy with intravenous
gamma-globulin was started. He did not respond to
beta-human chorionic gonadotropin therapy for undes-
cended testicles. At age 2 years 10 mo the patient was
diagnosed with hypertension. At age 3 years 3 mo, the
patient was referred for cytogenetic analysis for sus-
pected PWS, because of hypotonicity, small testicles, fail-
ure to thrive, and poor sucking reflex during infancy,
followed by an eating behavior leading to an increased
weight gain at age 2 years and to obesity (197%-ile for
weight, at age 3 years). In addition, the patient was noted
to have narrow bifrontal diameter, almond-shaped, up-
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Figure 1 Patient at age 3 years 3 mo. Note the midface hypo-
plasia, almond-shaped eyes, and up-slanted palpebral fissures. The
patient’s parents also were relatively light in complexion.
Figure 2 G-banded chromosomes of translocation
(4;15)(q27;q11.2). High-resolution chromosome analysis demon-
strated an apparently balanced translocation between the long arms
of chromosome 4, at band q27, and chromosome 15, at band q11.2
(arrows).
slanted palpebral fissures (see fig. 1), narrow arched pal-
ate, and undescended testes. At age 11 years the patient
had a combined score of 10 points; a minimum of 5 is
required for an individual to be considered positive for
PWS. The consensus diagnostic criteria (Holm et al.
1993) were evaluated for this patient. The major criteria
(1 point each) include hypotonia in the neonatal period,
with decreased sucking reflex; failure to thrive during
infancy and early childhood; rapid weight gain at age
11 year (in this case, at age 2 years); hypogonadism;
developmental delay; hyperphagia (aggressive food-
seeking behavior); and deletion or other structural ab-
normality of 15q11-13. Minor criteria ( point each)12
include decreased in utero activity, behavioral abnor-
malities (temper tantrums; violent outbursts and obses-
sive-compulsive, rigid, argumentative, oppositional,
and/or stubborn behavior; and/or lying), sleep dis-
turbances/apnea, viscous saliva, articulation difficulty,
and skin picking. Supportive (but otherwise not scored)
findings include decreased vomiting and normal neu-
romuscular studies (creatine phosphokinase and aldol-
ase normal). It is of interest that the patient did not have
(1) small hands and feet, (2) hypopigmentation, (3) nar-
row hands with straight ulnar border, (4) or esotropia/
myopia. PWS patients of African American ancestry
have been reported to have larger hand and foot lengths,
compared with Caucasian PWS patients, which is con-
sistent with what was seen in our patient (Cassidy et al.
1996).
Cytogenetic Analysis
A high-resolution, GTW-banded (Seabright 1971)
chromosome study was performed on the patient and
his parents, as described elsewhere (Yunis and Chandler
1977). Forty cells from the patient and 20 cells from
each parent were analyzed in detail.
FISH
YACs were obtained from Craig Chinault and Uta
Francke and were grown by standard methods. Correct
insert sizes were confirmed by use of contour-clamped
homogeneous electric field (CHEF) pulse-field gel elec-
trophoresis (Chu et al. 1986). FISH was performed by
standard techniques (Dracopoli et al. 1997), with bio-
tinylated whole-yeast DNA, and visualization was with
FITC-streptavidin on a Zeiss Photomicroscope III.
Somatic-Cell Hybrids
A lymphoblastoid cell line from the patient with the
translocation (4;15) was established by Epstein-Barr vi-
rus (EBV) transformation, was fused with a hypoxan-
thine phosphoribosyltransferase–deficient Chinese ham-
ster ovary (CHO) cell line (Y21) (a gift kindly provided
by Roger Schultz), and was propagated at low density
in hypoxanthine-amethopterin-thymidine (HAT) me-
dium for 2 wk, to select for heterokaryons (Dracopoli
et al. 1997). Human parental lymphoblastoid cells were
removed by shaking the media prior to feeding. Cells
were cultured for a minimum of 10 generations and then
were dispersed into 80 separate 24-well microtiter plates
(i.e., a total of 1,920 cultures), at a dilution that would
result in 0.3 cells/well, and were selected for analysis.
DNA was isolated and used for PCR analysis using prim-
ers for two loci, D15S18 and GABRB3, that are on op-
posite sides of the PWS chromosomal region. Ten clones
from each of two categories were identified; those in the
first category, which had segregated der(15) (i.e., the
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Figure 3 Map of translocation breakpoint. Mapping panels were
constructed for both PCR and Southern blotting, to refine the break-
point in the proband. These panels consisted of an unaffected human
control, a CHO control, mch200.3, YRS-1 a somatic cell hybrid con-
taining der(15) (15pterrq11.2) but not the normal 15, and YRG-1 a
somatic cell hybrid containing der(4) (15q11.2rqter) but not the nor-
mal 15. The locus D15S11 (∼260 bp) was amplified in the human,
mch200.3, and YRS-1 samples but not in the CHO or YRG-1 samples,
indicating that this locus is proximal to the breakpoint. The same was
observed for locus D15S128 (˜200 bp). Conversely, locus GABRB3
(˜180 bp) was amplified in the human, mch200.3, and YRG-1 samples
but not in the YRS-1 sample, indicating that it is distal to the break-
point. These loci are polymorphic and therefore have different-sized
products.
Figure 4 Map of SNRPN relative to translocation breakpoint.
SNRPN exons 1–3 were amplified in each of the DNA samples, which
showed that exons 1 and 2 are proximal to the breakpoint, since they
were present in YRS-1 but not in YRG-1, whereas exon 3 was distal
to the breakpoint, since it was present in YRG-1 but not in YRS-1.
derivative chromosome 15) from both the normal chro-
mosome 15 and der(4) and were positive only for
D15S18, were designated “YRS,” and those in the sec-
ond category, which segregated der(4) from both the
normal 15 and der(15) and were positive only for
GABRB3, were designated “YRG.” A mouse-human hy-
brid cell line (mch200.3) (a generous gift from Eric Stan-
bridge), containing chromosome 15 as its only human
contribution, also was used, for the construction of the
mapping panel.
Southern Blotting
Plasmid probes D15S18 (pIR39), ZNF127 (pTD34),
D15S11 (pIR4-3), D15S13 (pTD189-1), D15S10
(pTD3-21), and P (pIR10-1) were from Donlon et al.
(1986). The probe for SNRPN exons 4–10 (previously
referred to as exons “2”–“8”) was from Stuart Leff (O¨z-
c¸elik et al. 1992). The probe for D15S63 (pW71B) was
from Bernhard Horsthemke (Dittrich et al. 1993). The
probe for D15S24 (pCMW-1) was from David Ledbetter
(Rich et al. 1988).
Methylation Studies
Methylation studies were performed on loci DN34/
ZNF127 (EcoRI/HpaII digested), SNRPN exon 1 (pre-
viously “1”) (NotI/XbaI digested), and D15S63
(HindIII/HpaII digested), as described elsewhere (Dit-
trich et al. 1993; Glenn et al. 1993a, 1996).
PCR
PCR on somatic-cell hybrid DNA was performed for
loci D15S18, D15S13, D15S10, D15S113, D15S12,
D15S97, and GABRB3, as originally described by Ku-
wano et al. (1992) and Mutirangura et al. (1993).
SNRPN exons have been renamed to reflect the discov-
ery of two new exons, 1 and 2 (previously exons “1”
or “a” and “0” or “b,” respectively). SNRPN exon 1
was amplified by means of the following set of primers:
SNRPN-1F (5′-GTG GAG CGG CCG CC-3′) and
SNRPN-1R (5′-CTT GCC CGC TCC ATC G-3′), which
produced a 70-bp product. Exon 2 was amplified by
means of primers SNRPN0SHF (5′-GCA GTC TAC
CAA ACA AAT GCC) and SNRPN0SHB (5′-CCC AAC
ACA GTC TGT ACT CAC-3′), which produced a 154-
bp product. Exon 3 was amplified by means of primers
SNRPN1AF (5′GTT CTC AGC AGC AGC AAG-3′) and
SNRPN1AR (5′-CAG ATT CCT CGC TAC TC-3′),
which produced a 112-bp product. Primers for exons 1
and 3 are within the coding segment, whereas the prim-
ers for exon 2 are present in flanking intronic DNA.
Primers for D15S225E, D15S226E (PAR5) , D15S227E
(PAR1), D15S228E (PAR4), and D15S229E (PAR7) are
from Sutcliffe et al. (1994). IPW is from Wevrick et al.
(1994). Primers for loci 71B11L, A156E1R, 30A12L,
B58C7R, 132D4R, B230E3L, B230E3R, 189 1-CA, and
307ARL were generous gifts from David Ledbetter and
Susan Christian. The remaining primer sequences were
obtained from the Genome Database. All primers were
synthesized by Operon Technologies. PCR conditions
for the SNRPN primers sets were 94C for 4 min, fol-
lowed by 35 cycles of 94C for 1 min, 58C for 30 s,
and 72C for 10 s, and a final elongation at 72C for 7
min.
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Figure 5 Localization of translocation breakpoint. The locations of 28 loci relative to the translocation (4;15)(q27;q11.2) breakpoint are
shown. The breakpoint was localized to the region between SNRPN exons 2 and 3. The horizontal bars represent YACs and their respective
anchor points (i.e., sequence-tagged sites). (Redrawn from Mutirangura et al. 1993)
Table 1
Parental Origin of Translocation
SAMPLE
ALLELE(S) AT LOCUSa
D15S11 D15S128 D15S113 GABRB3 D15S98
Father B/C A/C A/B A/B B/C
Mother A/D A/B A C/D A/C
Patient B/D AC A/B A/C A/C
YRS-1 B C ) ) )
YRG-1 ) ) B A C
a Paternal alleles are underlined.
Gene expression was assayed by reverse transcrip-
tion–PCR (RT-PCR), as described elsewhere (O¨zc¸elik et
al. 1992; Glenn et al. 1993b; Sutcliffe et al. 1994; Wev-
rick et al. 1994). SNRPN exon 2 was assayed by means
of intraexonic primers SNRPN0AF (5′-AGA ACA GCA
CGT ACC AGA GG-3′) and SNRPN0AR (5′-TCT TGG
TTG CTC AGT GAG GC-3′), which produced a 68-bp
product. The transcript including SNRPN exons 1 and
2 was assayed by means of primers SNRPN-1F (5′-CTG
ACG CAT CTG TCT GAG GA-3′) and SNRPN0R (5′-
TTC GTC TCA GGT GTA AGC GA-3′), which pro-
duced a 72-bp product. The transcript including SNRPN
exons 2 and 3 was assayed by means of primers
SNRPN0F (5′-GGA AGT CCA AGT CAA ACG C-3′)
and SNRPN1R (5′-CCT CGC TAC TCC AAT ATG GC-
3′), which produced a 175-bp product. RT-PCR was per-
formed on ZNF127, SNRPN (exon 1), SNRPN (exon
2), SNRPN (exon 3), SNRPN (exons 1 and 2), SNRPN
(exons 2 and 3), SNRPN (exons 4 and 5), D15S226E
(PAR5), IPW, and D15S227E (PAR1). All RNA samples
were treated with 200 U RNAse-free DNAse I (Sigma)
for 1 h at 37C, followed by a heating to 68C for 10
min, prior to first-strand cDNA synthesis. The integrity
of RNA and the absence of genomic DNA were assayed
by means of primers for b-actin (CloneTech) and for
SNRPN exons 4 and 5, both of which are interexonic
primer sets. cDNA was generated by incubation of 1 mg
RNA in a volume of 20 ml containing 1.5 mM MgCl2,
1.0 mM of each dNTP, 2.5 mM reverse primer, and 25
U Moloney murine leukemia virus (New England Bio-
labs), at 42C for 1 h. This cDNA was then amplified
by 35 cycles of PCR, by addition of the cDNA to a
volume of 100 ml, which included 1.5 mM MgCl2, 0.2
mM of each dNTP, 0.5 mM forward primer, and 1.25
U Taq polymerase (Perkin Elmer Cetus), with denatur-
ation at 94C for 1 min, annealing at 58C for 30 s, and
elongation at 72C for 30 s, in a volume of 100 ml.
Results
High-resolution chromosome analysis demonstrated
an apparently balanced translocation between the long
arms of chromosomes 4 and 15, with breakpoints ten-
tatively localized to 15q11.2 (fig. 2). Parental chromo-
somes were normal, indicating that the child’s translo-
cation was de novo (not shown). FISH was performed
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Figure 6 RT-PCR of genes IPW and SNRPN. The patient ex-
presses the IPW gene but not the SNRPN gene. From left to right, the
lanes show a 100-bp size ladder (leftmost, unlabeled lane) and the
IPW RT-PCR product (˜410 bp) from a normal control (first lane N),
results for patient PWS (lane R79), SNRPN exons 4 and 5 RT-PCR
product (˜160 bp) from a normal control (second lane N), and results
for the patient in the present study.
Table 2
RT-PCR of 11 Transcripts from PWS
Chromosomal Region
Locus Expressed?
ZNF127 Yes
SNRPN:
Exon 1 Yes
Exons 1 and 2 Yes
Exon 2 Yes
Exons 2 and 3 No
Exon 3 No
Exons 1–3 No
Exons 4 and 5 No
D15S226E (PAR5) No
IPW Yes
D15S227E (PAR1) Yes
with YAC DNA as probe and demonstrated that the
breakpoint lies between D15S18 and D15S10 (data not
shown).
Somatic-cell hybrids were constructed by use of the
patient’s chromosomes, to separate the normal chro-
mosome 15, der(4), and der(15), thereby facilitating the
construction of mapping panels to refine further the
breakpoint in the patient’s chromosome 15. Figure 3
shows an example of a mapping panel indicating that
loci D15S11 and D15S128 are proximal (i.e., present in
hybrid YRS-1 but not in YRG-1) whereas GABRB3 is
distal. Southern blot analysis of six loci and PCR am-
plification of 22 loci revealed that the breakpoint lies
between D15S128 and SNRPN exons 4–10. PCR prim-
ers were constructed for SNRPN exons 1 (previously
exon “1” or “a”), exon 2 (previously exon “0” or
“b”), and exon 3 (previously exon “1”) and show that
the breakpoint lies between exons 2 and 3 (fig. 4). The
mapping results for all 28 loci are shown in figure 5.
The parental origin of this translocation was deter-
mined by comparison of five polymorphic loci in the
parents versus those in the somatic-cell hybrids (table
1). Informative loci include D15S11, D15S128,
D15S113, and GABRB3 and demonstrate a paternal or-
igin of the translocation chromosome; the paternal allele
present in the hybrid is shown underlined in table 1.
Methylation studies were conducted to ascertain the im-
print status of loci ZNF127, SNRPN, and PW71B (Dit-
trich et al. 1993; Glenn et al. 1993a, 1996) . All three
loci showed normal methylation patterns, indicating
normal biparental inheritance. (i.e., methylated on the
maternal chromosome 15 but unmethylated on the pa-
ternal 15; data not shown).
RT-PCR was conducted to assay the expression of
genes in the PWS chromosomal region—that is,
ZNF127, SNRPN exons 1–5, D15S226E (PAR5), IPW,
and D15S227E (PAR1). Figure 6 shows that SNRPN
exons 4 and 5 were not expressed, whereas IPW was.
In addition, this patient did express ZNF127, SNRPN
exon 1, SNRPN exon 2, SNRPN exons 1 and 2, and
D15S227E (PAR1) but did not express SNRPN exon 3,
SNRPN exons 2 and 3, and D15S226E (PAR5), as
shown in table 2.
Discussion
The ICE (Sutcliffe et al. 1994; Buiting et al. 1995)
contains at least five transcription units that are part of
the SNRPN gene and that are alternately spliced during
fetal development (Dittrich et al. 1996). These upstream
transcripts appear to control the paternalrmaternal im-
print switch and are defective in Angelman syndrome
patients with imprinting mutations (i.e., two paternally
imprinted chromosomes), whereas deletions of SNRPN
exon 1 are involved in the maternalrpaternal imprint
switch and are defective in PWS patients with imprinting
mutations (i.e., two maternally imprinted chromo-
somes). The paternal pattern of imprinting appears to
be the default status for the genes that have been char-
acterized thus far (Dittrich et al. 1996). The breakpoint
in our patient was found to lie between SNRPN exons
2 and 3 and therefore is believed to be outside the ICE.
We have shown both normal expression of three of five
genes examined and normal methylation at three of three
loci. Although we know that there are both methylated
and unmethylated versions of each gene, we assume that
the unmethylated (paternal) alleles are on the derivative,
translocation chromosomes, since we have determined
it to be paternal in origin. It is not possible to determine
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whether this translocation disrupts the imprint status of
these three loci, because we do not have the opportunity
to study further generations of this de novo rearrange-
ment. Likewise, we will not be able to address issues of
imprint initiation, spreading, or maintenance in our pa-
tient. The translocation breakpoint is presumably far
enough from the ICE that it should have little or no
impact on the functions of the ICE. There is only one
gene, UBE3A, distal to this patient’s breakpoint, that is
known to be maternally imprinted; however, UBE3A is
imprinted only in brain and during a short time during
embryogenesis, thus precluding analysis in our patient.
Since we have shown both normal methylation pat-
terns of three loci on this patient’s chromosomes 15 and
normal expression of three of five loci, we surmise that
the full PWS phenotype can be manifested by the lack
of SNRPN (exons 3–10) and/or D15S226E (PAR5) gene
expression. The fact that our patient did not express
D15S226E and SNRPN exons 4–10 suggest that
D15S226E is under the same regulatory control of
SNRPN and possibly is another 3′ exon. A similar PWS
patient has been described, by Sun et al. (1996), as hav-
ing a de novo balanced translocation breakpoint be-
tween SNRPN exons 2 and 3; however, Sun et al.’s pa-
tient expressed not only SNRPN exons 1 and 2 but also
SNRPN exons 3–10 from cultured fibroblast cells. Sun
et al. proposed that this expression of exons 3–10 was
the result of a fusion with an unidentified promoter on
chromosome 19. Similarities between that patient and
our patient include decreased fetal movement, hypo-
tonia, poor sucking reflex, narrow bifrontal diameter,
almond-shaped eyes, down-turned mouth, failure to
thrive in infancy and early childhood, rapid weight gain
at age 12 years, undescended testes, and lack of hypo-
pigmentation. One difference was that our patient had
normal length hands and feet, but this presumably is due
to his racial background (Cassidy et al. 1996).
Another report (Schulze et al. 1996) has described an
atypical PWS patient with a de novo balanced translo-
cation breakpoint between D15S226E and IPW. This
patient expressed SNRPN and D15S226E but neither
IPW nor D15S227E (PAR1). It should be noted, how-
ever, that EBV-transformed cells, which, with respect to
methylation and gene expression, are notorious for dif-
fering from in vivo cell types, were used for the analysis
of this patient. Another report (Conroy et al. 1997) has
described an “atypical” PWS patient with a balanced de
novo translocation breakpoint between SNRPN and
IPW, with expression, from EBV-transformed lympho-
blasts, of SNRPN (distal exons) and D15S226E but with
no expression of IPW and D15S227E. Collectively, these
cases indicate that both the expression of SNRPN exons
1–3 and colinearity with distal loci are necessary to pre-
vent the PWS core phenotypic features. It appears that
expression of both SNRPN/D15S226E and IPW/
D15S227E are necessary for prevention of PWS. The
four mutations described thus far, which include that in
our patient, have occurred on the father’s chromosome
15, but it is not known whether they occurred on the
father’s maternal or paternal copy. Loci that are distal
to such a translocation would be expected to retain the
grandparental imprint pattern. Although our patient ex-
pressed IPW and D15S227E, our analyses were per-
formed on RNA extracted from peripheral blood and
may not reflect the levels found in brain during fetal
development. Similarly, other reports of PWS patients
with balanced translocations have dealt with expression
from either cultured fibroblasts or peripheral blood and
may not reflect the levels found in brain tissues during
early development.
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